CATHY KLEMA
CIK 1181157 · last filed 2026-06-10
CATHY KLEMA is a corporate insider who has filed 36 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for OPRX, was dated Jun 10, 2026. Across all open-market trades the lifetime net is −$2.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $293.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$293.6K
7
36
-$2.48M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OPRX | Director | 56,137 | $5.23 | $293.6K | $0 | 5 | 2026-06-10 |
| Allergan plc (AGN) Delisted | Director | 25,081 | — | — | $0 | 3 | 2019-05-02 |
| Allergan plc (AGNpA) Delisted | Director | 23,639 | — | — | $0 | 4 | 2017-05-05 |
| Allergan plc (ACTpA) Delisted | Director | 21,027 | — | — | $0 | 1 | 2015-06-08 |
| ACT | Director | 0 | $42.41 | $0 | $0 | 1 | 2013-10-02 |
| Actavis, Inc. (WPI) Delisted | Director | 44,432 | — | — | -$1.70M | 7 | 2012-08-01 |
| PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Director | 16,199 | — | — | -$774.3K | 12 | 2011-01-04 |
Recent Filings
36 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-10 | OPRX | Grant (A) | +34,517 | $0 | EDGAR |
| 2025-06-12 | OPRX | Grant (A) | +9,868 | $0 | EDGAR |
| 2025-02-04 | OPRX | Exer (M) | +5,109 | $0 | EDGAR |
| 2024-06-11 | OPRX | Grant (A) | +6,643 | $0 | EDGAR |
| 2024-02-06 | OPRX | Grant (A) | — | $0 | EDGAR |
| 2019-05-02 | Allergan plc (AGN) Delisted | Tax (F) | −953 | -$140.1K | EDGAR |
| 2019-03-13 | Allergan plc (AGN) Delisted | Other (J) | +410 | $0 | EDGAR |
| 2018-05-04 | Allergan plc (AGN) Delisted | Grant (A) | +1,985 | $299.9K | EDGAR |
| 2017-05-05 | Allergan plc (AGNpA) Delisted | Grant (A) | +1,223 | $299.9K | EDGAR |
| 2016-08-09 | Allergan plc (AGNpA) Delisted | Grant (A) | +201 | $49.9K | EDGAR |